EFMC International Symposium on Medicinal Chemistry 2021

View Full Event Details

The event had been postponed due to concerns about COVID-19.

The event will cover advances in drug discovery in major therapeutic areas, including the treatment of bacterial and viral infections, diseases related to the central nervous system, heart disease, fibrotic diseases, and cancer. It will also present advances in areas such as the application of artificial intelligence in drug discovery and in synthesis, carbohydrate recognition and drug design, the targeting of RNA, small molecule-induced stem cell differentiation, and the impact of cryo-EM on drug discovery and design.

In chemical biology sessions, the interface between chemical biology and drug discovery will be highlighted by discussing the use of chemical probes for target discovery, aspects of molecular imaging, and photochemical approaches. Several sessions will be dedicated to advances in synthetic methodology for drug discovery.

Selected Speakers

• Prof. Ad P. IJZERMAN, LEIDEN UNIVERSITY, Leiden, The Netherlands
• Dr Malin LEMURELL, ASTRAZENECA, Gothenburg, Sweden
• Dr John E. MACOR, SANOFI, Waltham, United States
• Prof. Gisbert SCHNEIDER, ETH ZÜRICH, Zürich, Switzerland
• Prof. Stephan A. SIEBER, TECHNICAL UNIVERSITY MUNICH, Garching, Germany
• Prof. Phil BARAN, THE SCRIPPS RESEARCH INSTITUTE, La Jolla, United States
• Dr Karin BRINER, NOVARTIS, Cambridge, United States
• Dr Jean-Paul CLOZEL, IDORSIA PHARMACEUTICALS LTD, Allschwil, Switzerland
• Prof. Stefan KNAPP, GOETHE UNIVERSITY FRANKFURT, Frankfurt am Main, Germany

Article Views: 65